Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-12-28 18:07 | 2010-12-27 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.47 | 12,500 | $5,875 | 5,320,000 |
| 2010-12-28 00:03 | 2010-12-23 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $6.70 | 8,203 | $54,960 | 28,581 |
| 2010-12-24 00:01 | 2010-12-20 | ATRC | AtriCure, Inc. | Discovery Group I, LLC | 10% owner | BUY | $10.00 | 1,000 | $9,996 | 1,429,079 |
| 2010-12-24 01:56 | 2010-12-22 | CYTX | PLUS THERAPEUTICS, INC. | CALHOUN CHRISTOPHER J | Director, Officer | SELL | $5.69 | 48,125 | $273,908 | 83,125 |
| 2010-12-23 00:39 | 2010-12-22 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $6.70 | 500 | $3,350 | 28,581 |
| 2010-12-23 01:11 | 2010-12-22 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.46 | 12,500 | $5,750 | 5,307,500 |
| 2010-12-22 17:00 | 2010-12-21 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.45 | 22,000 | $9,900 | 5,295,000 |
| 2010-12-22 02:22 | 2010-12-17 | RMD | RESMED INC | Gallahue Kieran | Director, Officer | OPT+S | $35.00 | 20,000 | $700,000 | 56,922 |
| 2010-12-21 16:59 | 2010-12-17 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.46 | 32,000 | $14,720 | 5,273,000 |
| 2010-12-21 00:12 | 2010-12-16 | PODD | INSULET CORP | DePietro Ruthann | Officer | OPT+S | $15.00 | 1,500 | $22,500 | 8,371 |
| 2010-12-21 01:59 | 2010-11-29 | BDX | BECTON DICKINSON & CO | DURACK DAVID T | Officer | OPT+S | $79.79 | 3,062 | $244,309 | 8,382 |
| 2010-12-18 01:10 | 2010-12-15 | RMD | RESMED INC | PENDARVIS DAVID | Officer | OPT+S | $35.00 | 59,612 | $2,086,420 | 25,725 |
| 2010-12-18 03:38 | 2010-12-16 | ARAY | Accuray Incorporated | Raanes Chris | Officer | OPT+S | $6.51 | 6,000 | $39,065 | 58,572 |
| 2010-12-18 00:30 | 2010-12-17 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.47 | 27,500 | $12,925 | 5,241,500 |
| 2010-12-17 17:42 | 2010-12-16 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.49 | 14,000 | $6,860 | 5,214,000 |
| 2010-12-18 00:47 | 2010-12-15 | BAX | BAXTER INTERNATIONAL INC | Batchelor Phillip L. | Officer | OPT+S | $51.79 | 6,000 | $310,740 | 16,995 |
| 2010-12-16 20:10 | 2010-12-15 | MMSI | MERIT MEDICAL SYSTEMS INC | LAMPROPOULOS FRED P | Director, Officer | SELL | $15.71 | 5,000 | $78,560 | 745,369 |
| 2010-12-15 19:25 | 2010-11-12 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $33.70 | 12,953 | $436,516 | 37,326 |
| 2010-12-15 19:24 | 2010-11-11 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $33.70 | 21,047 | $709,284 | 40,871 |
| 2010-12-16 00:31 | 2010-12-15 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.48 | 15,000 | $7,200 | 5,200,000 |
| 2010-12-14 23:23 | 2010-12-13 | ADMD | VIVOS INC | RATCHFORD BRUCE WAYNE | Director | BUY | $0.45 | 3,000 | $1,350 | 5,321,044 |
| 2010-12-15 00:50 | 2010-12-10 | HAE | HAEMONETICS CORP | LINDOP CHRISTOPHER J | Officer | OPT+S | $62.48 | 17,832 | $1,114,220 | 11,097 |
| 2010-12-15 01:50 | 2010-12-14 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.47 | 15,500 | $7,285 | 5,185,000 |
| 2010-12-13 22:58 | 2010-12-10 | ADMD | VIVOS INC | RATCHFORD BRUCE WAYNE | Director | BUY | $0.42 | 3,000 | $1,260 | 5,318,044 |
| 2010-12-14 00:37 | 2010-12-09 | ARAY | Accuray Incorporated | Thomson Euan | Officer | OPT+S | $6.10 | 25,000 | $152,445 | 143,300 |
| 2010-12-10 20:31 | 2010-12-06 | ADMD | VIVOS INC | RATCHFORD BRUCE WAYNE | Director | BUY | $0.45 | 3,300 | $1,485 | 5,315,044 |
| 2010-12-10 21:55 | 2010-12-10 | UTMD | UTAH MEDICAL PRODUCTS INC | Beeson James H | Director | BUY | $28.00 | 1,000 | $28,000 | 1,400 |
| 2010-12-11 00:56 | 2010-12-10 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.48 | 16,200 | $7,776 | 5,169,500 |
| 2010-12-10 21:34 | 2010-12-09 | BDX | BECTON DICKINSON & CO | SHERMAN JEFFREY S | Officer | SELL | $81.55 | 1,127 | $91,907 | 23,726 |
| 2010-12-09 01:17 | 2010-12-06 | UFPT | UFP TECHNOLOGIES INC | BAILLY RICHARD L | Director | SELL | $11.62 | 5,000 | $58,100 | 19,734 |
| 2010-12-09 01:16 | 2010-12-06 | UFPT | UFP TECHNOLOGIES INC | Pierce Robert W Jr | Director | BUY | $11.62 | 5,000 | $58,100 | 17,000 |
| 2010-12-09 05:33 | 2010-12-06 | RMD | RESMED INC | Gallahue Kieran | Director, Officer | OPT+S | $33.15 | 30,000 | $994,476 | 56,922 |
| 2010-12-09 00:38 | 2010-12-07 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | HENNEMAN JOHN B III | Officer | SELL | $47.46 | 5,324 | $252,677 | 84,424 |
| 2010-12-09 01:09 | 2010-12-06 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $6.70 | 397 | $2,660 | 28,581 |
| 2010-12-09 01:05 | 2010-12-08 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.47 | 22,183 | $10,426 | 5,153,300 |
| 2010-12-09 00:41 | 2010-12-08 | BDX | BECTON DICKINSON & CO | COHEN GARY M | Officer | SELL | $81.10 | 9,000 | $729,900 | 78,863 |
| 2010-12-08 00:17 | 2010-12-03 | HAE | HAEMONETICS CORP | LOPEZ ALICIA R | Officer | OPT+S | $60.91 | 96,656 | $5,887,124 | 11,017 |
| 2010-12-07 23:34 | 2010-12-06 | HAE | HAEMONETICS CORP | HANLON SUSAN M | Officer | OPT+S | $60.99 | 3,500 | $213,465 | 6,584 |
| 2010-12-08 01:03 | 2010-12-07 | LMAT | LEMAITRE VASCULAR INC | LeMaitre Cornelia W | Director, Officer | SELL | $6.50 | 50,000 | $325,000 | 288,606 |
| 2010-12-08 00:54 | 2010-12-07 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.48 | 26,300 | $12,624 | 5,131,117 |
| 2010-12-07 17:02 | 2010-12-06 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.46 | 22,730 | $10,456 | 5,104,817 |
| 2010-12-07 05:55 | 2010-12-01 | BVX | Apyx Medical Corporation | Pardoll Peter | Director | SELL | $3.12 | 28,256 | $88,198 | 2,500 |
| 2010-12-06 21:41 | 2010-12-03 | SNWV | SANUWAVE Health, Inc. | Nemelka David Nephi Jr. | 10% owner | BUY | $0.00 | 75,000 | $0 | 453,007 |
| 2010-12-06 17:16 | 2010-12-03 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.46 | 75,257 | $34,618 | 5,082,087 |
| 2010-12-07 01:58 | 2010-12-06 | BDX | BECTON DICKINSON & CO | COHEN GARY M | Officer | OPT+S | $81.09 | 23,356 | $1,893,938 | 87,863 |
| 2010-12-07 01:06 | 2010-12-03 | BDX | BECTON DICKINSON & CO | BECTON HENRY P JR | Director | OPT+S | $80.65 | 2,061 | $166,220 | 17,236 |
| 2010-12-04 00:55 | 2010-12-02 | IART | INTEGRA LIFESCIENCES HOLDINGS CORP | ESSIG STUART | Director, Officer | SELL | $45.20 | 100,000 | $4,519,830 | 840,312 |
| 2010-12-04 02:15 | 2010-12-02 | LMAT | LEMAITRE VASCULAR INC | Gebauer Peter R | Officer | OPT+S | $6.70 | 700 | $4,690 | 28,581 |
| 2010-12-04 02:48 | 2010-12-02 | ARAY | Accuray Incorporated | Raanes Chris | Officer | OPT+S | $6.07 | 6,000 | $36,411 | 58,572 |
| 2010-12-03 17:26 | 2010-12-02 | GTF | Nuo Therapeutics, Inc. | JORDEN DAVID EMERSON | Director | BUY | $0.46 | 37,792 | $17,384 | 5,006,830 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.